Biased and unbiased strategies to identify biologically active small molecules

被引:14
作者
Abet, Valentina [1 ]
Mariani, Angelica [1 ]
Truscott, Fiona R. [1 ]
Britton, Sebastien [2 ,3 ]
Rodriguez, Raphael [1 ]
机构
[1] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France
[2] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
[3] Univ Toulouse 3, Univ Toulouse, Equipe Labellisee Ligue Canc, F-31077 Toulouse, France
关键词
Drug discovery; Dynamic combinatorial chemistry; In situ click chemistry; Fragment-based drug discovery; Diversity-oriented synthesis; DIVERSITY-ORIENTED SYNTHESIS; SITU CLICK CHEMISTRY; DYNAMIC COMBINATORIAL CHEMISTRY; DEPENDENT KINASE INHIBITOR; FRAGMENT-BASED DISCOVERY; HISTONE DEACETYLASE INHIBITORS; POTENT AURORA KINASE; CELL-BASED ASSAYS; DRUG DISCOVERY; IN-SITU;
D O I
10.1016/j.bmc.2014.04.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small molecules are central players in chemical biology studies. They promote the perturbation of cellular processes underlying diseases and enable the identification of biological targets that can be validated for therapeutic intervention. Small molecules have been shown to accurately tune a single function of pluripotent proteins in a reversible manner with exceptional temporal resolution. The identification of molecular probes and drugs remains a worthy challenge that can be addressed by the use of biased and unbiased strategies. Hypothesis-driven methodologies employs a known biological target to synthesize complementary hits while discovery-driven strategies offer the additional means of identifying previously unanticipated biological targets. This review article provides a general overview of recent synthetic frameworks that gave rise to an impressive arsenal of biologically active small molecules with unprecedented cellular mechanisms. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:4474 / 4489
页数:16
相关论文
共 118 条
[1]   Iterative In Situ Click Chemistry Creates Antibody-like Protein-Capture Agents [J].
Agnew, Heather D. ;
Rohde, Rosemary D. ;
Millward, Steven W. ;
Nag, Arundhati ;
Yeo, Woon-Seok ;
Hein, Jason E. ;
Pitram, Suresh M. ;
Tariq, Abdul Ahad ;
Burns, Vanessa M. ;
Krom, Russell J. ;
Fokin, Valery V. ;
Sharpless, K. Barry ;
Heath, James R. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (27) :4944-4948
[2]   Fragment-based approaches and the prospect of fragmented prodrugs [J].
Antonow, Dyeison .
DRUG DISCOVERY TODAY, 2010, 15 (19-20) :801-803
[3]   A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies [J].
Arkenau, H. -T. ;
Plummer, R. ;
Molife, L. R. ;
Olmos, D. ;
Yap, T. A. ;
Squires, M. ;
Lewis, S. ;
Lock, V. ;
Yule, M. ;
Lyons, J. ;
Calvert, H. ;
Judson, I. .
ANNALS OF ONCOLOGY, 2012, 23 (05) :1307-1313
[4]   Click Chemistry and Bioorthogonal Reactions: Unprecedented Selectivity in the Labeling of Biological Molecules [J].
Best, Michael D. .
BIOCHEMISTRY, 2009, 48 (28) :6571-6584
[5]  
Bhat VT, 2010, NAT CHEM, V2, P490, DOI [10.1038/NCHEM.658, 10.1038/nchem.658]
[6]  
Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]
[7]   Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma [J].
Bollag, Gideon ;
Hirth, Peter ;
Tsai, James ;
Zhang, Jiazhong ;
Ibrahim, Prabha N. ;
Cho, Hanna ;
Spevak, Wayne ;
Zhang, Chao ;
Zhang, Ying ;
Habets, Gaston ;
Burton, ElizabethA. ;
Wong, Bernice ;
Tsang, Garson ;
West, Brian L. ;
Powell, Ben ;
Shellooe, Rafe ;
Marimuthu, Adhirai ;
Nguyen, Hoa ;
Zhang, Kam Y. J. ;
Artis, Dean R. ;
Schlessinger, Joseph ;
Su, Fei ;
Higgins, Brian ;
Iyer, Raman ;
D'Andrea, Kurt ;
Koehler, Astrid ;
Stumm, Michael ;
Lin, Paul S. ;
Lee, Richard J. ;
Grippo, Joseph ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
Chapman, Paul B. ;
Flaherty, Keith T. ;
Xu, Xiaowei ;
Nathanson, Katherine L. ;
Nolop, Keith .
NATURE, 2010, 467 (7315) :596-599
[8]   Rescuing combichem [J].
Borman, S .
CHEMICAL & ENGINEERING NEWS, 2004, 82 (40) :32-+
[9]   Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation [J].
Bourne, Y ;
Kolb, HC ;
Radic, Z ;
Sharpless, KB ;
Taylor, P ;
Marchot, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (06) :1449-1454
[10]   Thermodynamically-controlled cyclisation and interconversion of oligocholates: metal ion templated 'living' macrolactonisation [J].
Brady, PA ;
Sanders, JKM .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1997, (21) :3237-3253